Stereoselective syntheses of the glycosidase inhibitors hyacinthacine A2, hyacinthacine A3 and 5-epi-hyacinthacine A3

Tetrahedron

Volumn 65, Issue 34, 2009, Pages 6965-6971

  Ribes, Celia ^a   Falomir, Eva ^a   Carda, Miguel ^a   Marco, J Alberto ^b  

^a UNIVERSITAT JAUME I   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 EPI HYACINTHACINE A3; ALKALOID; CARBON; DEXTRO SERINE; GLYCOSIDASE INHIBITOR; HYACINTHACINE A2; HYACINTHACINE A3; NITROGEN; PYRROLIZIDINE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION KINETICS; CYCLIZATION; EPIMER; LEGUME; MUSCARI ARMENIACUM; NONHUMAN; ONE POT SYNTHESIS; PHYTOCHEMISTRY; PRIORITY JOURNAL; STEREOCHEMISTRY; SYNTHESIS;

EID: 67650531431     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2009.06.046     Document Type: Article

References (47)

1. For general reviews on pyrrolizidine alkaloids, see:. Liddell J.R. Nat. Prod. Rep. 19 (2002) 773-781 and the previous papers in this series
2. Asano N., Kuroi H., Ikeda K., Kizu H., Kameda Y., Kato A., Adachi I., Watson A.A., Nash R.J., and Fleet G.W.J. Tetrahedron: Asymmetry 11 (2000) 1-8
3. For further reviews on the chemistry and biology of pyrrolizidine alkaloids, see:
4. Asano N., Nash R.J., Molyneux R.J., and Fleet G.W.J. Tetrahedron: Asymmetry 11 (2000) 1645-1680
5. Mroczek T., and Głowniak K. Proc. Phytochem. Soc. Eur. 47 (2002) 1-46
6. Fu P.P., Xia Q., Lin G., and Chou M.W. Drug Metab. Rev. 36 (2004) 1-55
7. Pyne S.G., and Tang M. Curr. Org. Chem. 9 (2005) 1393-1418
8. For recent reviews on syntheses of this compound class:
9. Yoda H. Curr. Org. Chem. 6 (2002) 223-243
10. Ayad T., Genisson Y., and Baltas M. Curr. Org. Chem. 8 (2004) 1211-1233
11. For representative examples, see:
12. Toyao A., Tamura O., Takagi H., and Ishibashi H. Synlett (2003) 35-38
13. Chabaud L., Landais Y., and Renaud P. Org. Lett. 7 (2005) 2587-2590
14. Kaliappan K.P., and Das P. Synlett (2008) 841-844
15. Izquierdo I., Plaza M.T., Tamayo J.A., Yáñez V., Lo Re D., and Sánchez-Cantalejo F. Tetrahedron 64 (2008) 4613-4618
16. For the use of non-sugar chiral starting materials, see for example:
17. Reddy P.K., Veyron A., Koos P., Bayle A., Greene A.E., and Delair P. Org. Biomol. Chem. 6 (2008) 1170-1172
18. Sengoku T., Satoh Y., Oshima M., Takahashi M., and Yoda H. Tetrahedron 64 (2008) 8052-8058
19. Donohoe T.J., Thomas R.E., Cheeseman M.D., Rigby C.L., Bhalay G., and Linney I.D. Org. Lett. 10 (2008) 3615-3618
20. Chandrasekar S., Parida B.B., and Rambabu C. J. Org. Chem. 73 (2008) 7826-7828
21. For previous syntheses of hyacinthacine A2 (2) see:
22. Rambaud L., Compain P., and Martin O.R. Tetrahedron: Asymmetry 12 (2001) 1807-1809
23. Cardona F., Faggi E., Liguori F., Cacciarini M., and Goti A. Tetrahedron Lett. 44 (2003) 2315-2318
24. Izquierdo I., Plaza M.T., and Franco F. Tetrahedron: Asymmetry 14 (2003) 3933-3935
25. Desvergnes S., Py S., and Vallée Y. J. Org. Chem. 70 (2005) 1459-1462
26. Dewi-Wülfing P., and Blechert S. Eur. J. Org. Chem. (2006) 1852-1856
27. 2)
28. 3 (3) see:. Izquierdo I., Plaza M.T., and Franco F. Tetrahedron: Asymmetry 13 (2002) 1581-1585
29. Ribes C., Falomir E., Murga J., Carda M., and Marco J.A. Org. Biomol. Chem. 7 (2009) 1355-1360
30. For a recent synthesis of radicamine B, a further pyrrolidine alkaloid which also contains the structural fragment I, see:. Ribes C., Falomir E., Carda M., and Marco J.A. J. Org. Chem. 73 (2008) 7779-7782
31. Pappo R., Allen Jr. D.S., Lemieux R.U., and Johnson W.S. J. Org. Chem. 21 (1956) 478-479
32. In our recent synthesis of the pyrrolizidine alkaloid australine, all three C-N bonds of the heterobicyclic system were formed in a one-pot procedure:. Ribes C., Falomir E., Carda M., and Marco J.A. Org. Lett. 9 (2007) 77-80
33. Tsuji J. In: Trost B.M., Fleming I., and Winterfeldt E. (Eds). Comprehensive Organic Synthesis Vol. 7 (1993), Pergamon, Oxford 449-468
34. Takacs J.M., and Jiang X.-T. Curr. Org. Chem. 7 (2003) 369-396
35. Cornell C.N., and Sigman M.S. Inorg. Chem. 46 (2007) 1903-1909
36. For previous syntheses of 5-epi-3, see Refs. 5c and d.
37. Hoveyda A.H., Evans D.A., and Fu G.C. Chem. Rev. 93 (1993) 1307-1370
38. The compound reported in Ref. 8 (numbered 4 there) is a dehydro derivative of 19 showing an additional C{double bond, long}C bond in the side chain. In the reaction conditions described by the authors, this compound was assumed to undergo hydrogenation to 19 (numbered 5) in a neutral medium as the first step. The acid was added to the reaction medium only after this initial step had taken place.
39. Lathbury D.C., Shaw R.W., Bates P.A., Hursthouse M.B., and Gallagher T. J. Chem. Soc., Perkin Trans. 1 (1989) 2415-2424
40. Provot O., Célérier J.-P., Petit H., and Lhommet G. J. Org. Chem. 57 (1992) 2163-2166
41. Oppolzer W., Bochet C.G., and Merifield E. Tetrahedron Lett. 35 (1994) 7015-7018
42. Dhimane H., Vanucci-Bacqué C., Hamon L., and Lhommet G. Eur. J. Org. Chem. (1998) 1955-1963
43. Takahata H., Takahashi S., Azer N., Eldefrawi A.T., and Eldefrawi M.E. Bioorg. Med. Chem. Lett. 10 (2000) 1293-1295
44. Stevens R.V., and Lee A.W.M. J. Am. Chem. Soc. 101 (1979) 7032-7035
45. Stevens R.V., and Lee A.W.M. J. Chem. Soc., Chem. Commun. (1982) 102-103
46. Stevens R.V., and Lee A.W.M. J. Chem. Soc., Chem. Commun. (1982) 103-104
47. 7d in the range 3-11% from commercial precursors. For 3 and 5-epi-3, the sequence contains 15 steps along the respective synthetic routes 5→16→3 and 5→16→5-epi-3. The overall yields were ca. 14% and 21%, respectively.